Acne and Rosacea: Special Considerations in the Treatment of Patients With Latin American Ancestry

J Drugs Dermatol. 2019 Mar 1;18(3):s124-126.

Abstract

Acne is a common disease among patients with Latin American ancestry. Its presentation is very similar to that in all skin types, but nodulocystic acne is more frequent in patients with oily and darker skin than in white Caucasians. Acne sequelae in patients with Latin American ancestry and with darker skin include postinflammatory hyperpigmentation (PIH) and atrophic and hypertrophic scars or keloids, with PIH being the most common complication affecting the quality of life of patients. Lately, more attention has been paid to rosacea in patients with darker skin. It has been seen that some of the patients, especially women, diagnosed with adult acne and who did not respond to treatment, were actually patients with rosacea. It is important to recognize the clinical characteristics of this disease in patients with darker skin in whom erythema and telangiectasia are difficult to observe. Here, we present the most relevant clinical characteristics of both diseases, as well as their treatment in patients with darker skin with Latin American ancestry. J Drugs Dermatol. 2019;18(3 Suppl):s124-126.

MeSH terms

  • Acne Vulgaris / complications
  • Acne Vulgaris / diagnosis
  • Acne Vulgaris / ethnology
  • Acne Vulgaris / therapy*
  • Administration, Cutaneous
  • Administration, Oral
  • Cicatrix, Hypertrophic / ethnology
  • Cicatrix, Hypertrophic / etiology
  • Cicatrix, Hypertrophic / prevention & control
  • Cosmeceuticals / therapeutic use
  • Cryosurgery
  • Dermabrasion / methods
  • Dermatologic Agents / therapeutic use*
  • Female
  • Hispanic or Latino*
  • Humans
  • Hyperpigmentation / etiology
  • Hyperpigmentation / prevention & control
  • Laser Therapy / methods
  • Male
  • Quality of Life
  • Rosacea / complications
  • Rosacea / diagnosis
  • Rosacea / ethnology
  • Rosacea / therapy*
  • Sex Factors
  • Skin Pigmentation / drug effects
  • Skin Pigmentation / physiology
  • Sunlight / adverse effects
  • Sunscreening Agents / administration & dosage
  • United States

Substances

  • Cosmeceuticals
  • Dermatologic Agents
  • Sunscreening Agents